Alzex Neuropharma FCF/Dettes

Que fait Alzex Neuropharma ? Alzex Neuropharma Inc, with ticker TRRI and ISIN US89656L1035, is a company based in Henderson, United States. It operates within the Materials sector, specifically in the Metals & Mining industry. The company went public on July 11, 2001. Its website is https://trinresinc.com/. According to the provided information, Alzex Neuropharma Inc engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. It is involved in research and development focused on treatments for brain diseases. The firm is also developing new drugs for the symptomatic treatment of Alzheimer’s Disease, leveraging a platform technology that may have applications for other neurological conditions. The company's activities include chemical development of its drug candidates. The information provided does not specify any founding year, key personnel, acquisitions, or detailed financial figures. The company's primary focus appears to be on neurological disease treatments, particularly Alzheimer’s, through its research and development efforts. Alzex Neuropharma est l'une des entreprises les plus populaires sur Eulerpool.